Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Clinicly Sp. z o.o.

Verified siteinfo

Poland Ul. Ludwika Warynskiego 30, 45-047 Opole, Poland

  • 4 trials recruiting
  • Graves' disease · Obesity
  • Adult patients

About Specializations

Clinicly Sp. z o.o. in Opole, Poland specialises in clinical trials of conditions such as Graves' disease, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

At Clinicly Sp. z o.o., researchers focus on Immune System Diseases, particularly Graves’ Disease. The trials aim to test a new therapeutic agent that restores normal thyroid hormone balance and reduces dependence on existing medication.

  • Evaluation of novel therapy for Graves’ Disease
  • Long‑term safety and durability of treatment
  • Assessment of hormone balance and medication reduction

The work is conducted at the Clinicly Sp. z o.o. Centrum Medyczne Clinicly in Opole, Poland.

Nutritional and Metabolic Diseases

The centre also investigates Nutritional and Metabolic Diseases, with emphasis on Obesity or Overweight without Type 2 Diabetes. Trials explore a potential weight‑management compound intended to achieve sustained body‑weight reduction.

  • Impact on body‑weight change over extended period
  • Safety profile in non‑diabetic participants
  • Effect on metabolic parameters and quality of life

These studies are part of the ongoing research program at Clinicly Sp. z o.o. in Opole.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Ludwika Warynskiego 3045-047 OpolePoland
Open in maps ↗
Recruiting now
4 trials
Conditions studied
2
Partner status
Verified site

More sites in OpolePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Graves' disease

Recruiting

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Graves' disease

Recruiting

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Graves' disease

Recruiting

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.